Stocks · Health care · Pharmaceutical Preparations

Xencor Inc

XNCR Clue Score24
United States Fiscal year ends December CIK 0001326732 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
John R Desjarlais
23 Jan 2026
Sr. Vice President & CSO
Exercised, kept
5,322
$12.51
$66.58K
Bassil I Dahiyat
22 Dec 2025
President & CEO
Exercised, kept
10,624
$12.51
$132.91K
John R Desjarlais
22 Dec 2025
Sr. Vice President & CSO
Exercised, kept
6,311
$12.51
$78.95K
Bassil I Dahiyat
3 Feb 2025
President & CEO
Exercised, kept
8,808
$15.69
$138.20K
John R Desjarlais
3 Feb 2025
Sr. Vice President & CSO
Exercised, kept
3,542
$15.69
$55.57K
Bassil I Dahiyat
22 Nov 2024
President & CEO
Exercised, kept
13,548
$15.69
$212.57K
John R Desjarlais
12 Nov 2024
Sr. Vice President & CSO
Exercised, kept
12,774
$15.69
$200.42K
John R Desjarlais
10 Jul 2024
Sr. Vice President & CSO
Exercised, kept
7,785
$10.73
$83.53K
John R Desjarlais
14 Feb 2024
Sr. Vice President & CSO
Exercised, kept
11,943
$11.05
$131.97K
John J Kuch
29 Jun 2021
Sr. Vice President & CFO
Exercised, kept
7,236
$15.69
$113.53K
John J Kuch
29 Jun 2021
Sr. Vice President & CFO
Exercised, kept
10,585
$11.05
$116.96K
John J Kuch
12 Jun 2020
Sr. Vice President & CFO
Exercised, kept
10,000
$11.05
$110.50K
John R Desjarlais
6 Sep 2019
Sr. V.P., Research & CSO
Exercised, kept
27,522
$4.25
$116.97K
Bruce L A Carter
24 May 2017
Director
Exercised, kept
76,744
$0.59
$45.28K

What was left out

Form 4 filings counted 241
Amendments (4/A) skipped 9
Filings about a different issuer 2
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 37
Sales at will 96
Transactions with no price 0
Shares from compensation/vesting 2,551,915
Sales filed before the plan box existed 64
History held since 6 Dec 2013